Craft

aap Implantate

Stock Price

€3.1

2021-01-28

Market Capitalization

€962 K

2021-01-28

Revenue

€12.5 M

FY, 2025

aap Implantate Summary

Company Summary

Overview
aap Implantate is a medical device company that specializes in trauma products for orthopedics. It offers LOQTEQ, an anatomical plating system for fracture treatment, cannulated screws, and standard plates. The company also provides Artosal, a fully synthetic osteoconductive bone substitute; Cerabone, a ceramic bone replacement material; PerOssal, a synthetic biodegradable osteostimulating and osteoconductive bone replacement material, etc.
Type
Public
Status
Active
Founded
1990
HQ
Berlin, DE | view all locations
Website
https://www.aap.de/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key People

  • Rubino Di Girolamo

    Rubino Di Girolamo, Chairman, CEO

  • Agnieszka Mierzejewska

    Agnieszka Mierzejewska, Member of the Management Board, COO

    Operating MetricsView all

    Countries

    25

    Q2, 2019

    LocationsView all

    2 locations detected

    • Berlin, Berlin HQ

      Germany

      5 Lorenzweg

    • Atlanta, GA

      United States

    aap Implantate Financials

    Summary Financials

    Revenue (FY, 2025)
    €12.5M
    Gross profit (FY, 2025)
    €11.7M
    Net income (FY, 2025)
    (€2.6M)
    Cash (FY, 2025)
    €661.0K
    EBIT (FY, 2025)
    (€2.7M)
    Enterprise value
    $648.0K

    Footer menu